Expensify, Inc.
For the period ended Mar 31, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 8, 2025
EXFY$1.85-9.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| As of March 31, | As of December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Cash and cash equivalents | $59,627 | $48,772 |
| Accounts receivable, net | 12,555 | 12,701 |
| Settlement assets, net | 50,038 | 42,406 |
| Prepaid expenses | 11,499 | 12,089 |
| Other current assets | 19,992 | 20,908 |
| Total current assets | 153,711 | 136,876 |
| Capitalized software, net | 15,232 | 16,232 |
| Property and equipment, net | 13,482 | 13,621 |
| Lease right-of-use assets | 5,269 | 5,441 |
| Deferred tax assets, net | 505 | 499 |
| Other assets | 1,037 | 1,011 |
| Total assets | $189,236 | $173,680 |
| Liabilities and stockholders' equity | ||
| Accounts payable | $526 | $196 |
| Accrued expenses and other liabilities | 9,732 | 8,240 |
| Lease liabilities, current | 738 | 729 |
| Settlement liabilities | 36,265 | 28,845 |
| Total current liabilities | 47,261 | 38,010 |
| Lease liabilities, non-current | 5,558 | 5,738 |
| Other liabilities | 1,766 | 1,689 |
| Total liabilities | 54,585 | 45,437 |
| Commitments and contingencies (Note 4) | ||
| Stockholders' equity: | ||
| Preferred stock, par value $0.0001; 10,000,000 shares authorized as of March 31, 2025 and December 31, 2024; no shares issued and outstanding as of March 31, 2025 and December 31, 2024 | — | — |
| Common stock, par value $0.0001Class A common stock; 1,000,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 80,380,404 and 79,471,414 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectivelyLT10 common stock; 21,871,197 shares authorized as of March 31, 2025 and December 31, 2024; 4,209,827 shares issued and outstanding as of March 31, 2025 and December 31, 2024LT50 common stock; 24,967,114 shares authorized as of March 31, 2025 and December 31, 2024; 7,793,436 and 7,695,524 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 9 | 9 |
| Additional paid-in capital | 288,639 | 279,062 |
| Accumulated deficit | (153,997) | (150,828) |
| Total stockholders' equity | 134,651 | 128,243 |
| Total liabilities and stockholders' equity | $189,236 | $173,680 |
See accompanying notes to Condensed Consolidated Financial Statements.
2
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.